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Utrecht, The NetherlandsObjective: To establish whichmeiotic checkpoints are activated inmales with severe spermatogenic impairment to improve phenotypic
characterization of meiotic defects.
Design: Retrospective observational study.
Setting: University medical center research laboratory and andrology clinic.
Patient(s): Forty-eight patients with conﬁrmed spermatogenic impairment (Johnsen scores 3–6) and 15 controls (Johnsen score 10).
Intervention(s): None.
Main Outcome Measure(s): Quantitative assessment of immunoﬂuorescent analyses of speciﬁc markers to determine meiotic entry,
chromosome pairing, progression of DNA double-strand break repair, crossover formation, formation of meiotic metaphases,
metaphase arrest, and spermatid formation, resulting in a novel classiﬁcation of human meiotic arrest types.
Result(s): Complete metaphase arrest was observed most frequently (27%), and the patients with the highest frequency of apoptotic
metaphases also displayed a reduction in crossover number. Incomplete metaphase arrest was observed in 17% of the patients. Only four
patients (8%) displayed a failure to complete meiotic chromosome pairing leading to pachytene arrest. Two new types of meiotic arrest
were deﬁned: premetaphase and postmetaphase arrest (15% and 13%, respectively).
Conclusion(s): Meiotic arrest in men occurs most frequently at meiotic metaphase. This arrest can be incomplete, resulting in low
numbers of spermatids, and often occurs in association with reduced crossover frequency. The phenotyping approach described here
provides mechanistic insights to help identify candidate infertility genes and to assess genotype-phenotype correlations in
individual cases. (Fertil Steril 2019;112:1059–70. 2019 by American Society for Reproductive Medicine.)
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because it involves induction and repair
of around 200DNAdouble-strand breaks
(DSBs) that are required for proper chro-
mosome pairing and crossover formation
(1). In mouse and man, these DSBs are
marked by accumulation of phosphory-
lated histone H2AX (gH2AX) (2, 3),
resulting in a nucleus-wide spreading of
many overlapping patches of gH2AX
signal upon immunostaining in early
meiotic prophase cells (leptotene and
zygotene). As DSB repair and chromo-
some pairing progress, this signal
declines, and the synaptonemal complex
(the protein complex that connects the1059
ORIGINAL ARTICLE: ANDROLOGYaxes of chromosomes) forms (reviewed in Zickler and Kleckner
[1]). This process is called synapsis andcanbe followedby immu-
nolocalization of synaptonemal complex components such as
synaptonemal complex protein 3 (SYCP3), allowing the identiﬁ-
cation of the different substages of meiotic prophase: leptotene,
zygotene, pachytene, and diplotene. When the synaptonemal
complex is completely formed, pachytene is reached. However,
the X and Y chromosome synapse only partially, due to lack of
homology in regions outside the so called pseudoautosomal re-
gion, and gH2AX concentrates on this DNA to facilitate forma-
tion of the transcriptionally silenced chromatin structure named
the XY body at the onset of pachytene (4, 5). In general, most of
the induced DSBs are repaired as noncrossovers, and only a
minority form crossovers (around 10%–20%, depending on the
species). During pachytene, crossovers are speciﬁcally marked
by accumulation of the mismatch repair protein MLH1 (6, 7).
At least one crossover per chromosome pair is required to
ensure proper segregation of chromosomes at the ﬁrst meiotic
metaphase-to-anaphase transition (1).Once thecells reachmeta-
phase, chromosomes accumulate phosphorylation of histone H3
at serine 10 (H3S10ph), and this marker can be used to identify
cells at this relatively brief stage (8).
Several meiotic checkpoints that operate during sper-
matogenesis have been described for mice (9–14). First, the
so-called pachytene checkpoint eliminates spermatocytes
in which chromosome synapsis is incomplete, and this is
functionally coupled to a failure to form the XY body in
male mice (14). In addition, a second checkpoint operates
during pachytene, sensing DNA damage (15, 16). If repair
and chromosome pairing occur normally, the next
checkpoint ensures correct segregation of chromosomes at
the metaphase-to-anaphase transition. This spindle assem-
bly checkpoint (SAC) functions in both mitosis and meiosis
and senses correct attachment of each chromosome to the
spindle. Anaphase only occurs after the SAC is satisﬁed
(11, 17–19).
In infertile men, occurrence of meiotic arrest phenotypes
has been described, and estimations of the percentage of
oligo- or azoospermic patients with meiotic arrest vary be-
tween 10% and 30% (20–28). In addition, detailed analyses
of different meiotic parameters, such as progression of
chromosome pairing and crossover formation, have been
performed in such patients (3, 21, 29–31). More recently,
RNA sequencing analyses have also been used to
characterize a small group of selected azoospermic patients
(32). However, in general, arrest phenotypes in azoospermic
or severely oligospermic men remain poorly characterized
and very few genetic causes of nonobstructive azoospermia
in men (often involving consanguinous families) have been
identiﬁed (33–36).
Here we aimed to obtain more insight into the types,
frequency, and completeness of meiotic arrest in men dis-
playing severe spermatogenic impairment. We hypothesize
that if spermatogenic impairment is caused by genetic fac-
tors, this will often lead to speciﬁc activation of one of the
above-described meiotic checkpoints and associated spe-
ciﬁc types of meiotic arrest. To assess meiotic arrest in rela-
tion to checkpoint activation, we set out to validate protein
markers that could be used for reliable identiﬁcation of1060cells arrested at different stages of spermatogenesis by
immunoﬂuorescent staining of parafﬁn-embedded testis
biopsy samples.
MATERIALS AND METHODS
Patient Inclusion and Genetic and Pathological
Results
This study used remnant parafﬁn-embedded testis biopsy ma-
terial from azoospermic or severely oligospermic patients or
from patients for whom testicular malignancy was suspected.
Material was collected from 462 patients between 2001 and
2013. The testis biopsies had been ﬁxed in 4% paraformalde-
hyde and embedded in parafﬁn. In these biopsies, the pathol-
ogy laboratory routinely analyzes histological patterns and
uses the quantitative histological grading system developed
by Johnsen (37) to assess spermatogenesis. In brief, the level
of sperm maturation is graded between 1 and 10, according
to the most advanced germ cell in the tubule, in at least 100
seminiferous tubules. Analyses of AZF deletions and/or com-
mon CFTR mutations and/or karyotyping were performed as
described (38).
Surplus ﬁxed biopsy samples were selected for the current
analysis, and we excluded the sample when [1] a malignancy
was reported in the biopsy, [2] the patient was known to carry
sex chromosome aberrations, [3] routine Johnsen score (JS)
(37) assessment was lacking and there was also no mention
of ‘‘maturation arrest’’ by the pathologist, and [4] no leftover
material was available.Ethics Approval
The use of surplus tissue samples was approved by the local
Institutional Review Board of the Erasmus MC Rotterdam
(METC 02.981). This included the permission to use the sec-
ondary tissue without further consent. Samples were used ac-
cording to the Code for Proper Secondary Use of Human
Tissue in The Netherlands developed by the Dutch Federation
of Medical Scientiﬁc Societies (FMWV, http://www.federa.
org/, version 2002, update 2011). This is a retrospective study
that was anonymized.Fluorescent Immunohistochemistry
Testis biopsies were sectioned (6 mm) and placed on a drop of
demineralized H2O (dH2O) on slides (Starfrost). After stretch-
ing the sections on a heating plate at 39oC, slides were dried
overnight at 37C. Subsequently, slides were placed at 60oC
for 1 hour. Then the slides were dewaxed and rehydrated as
follows: 3  5 minutes xylene, 3  5 minutes 100% ethanol,
and 3 5minutes phosphate-buffered saline (PBS). The slides
were then incubated for 15 minutes in Proteinase K in PBS
(1 mg/mL). This was followed by washing steps with dH2O (4
 2 minutes) and an incubation with terminal deoxynucleo-
tidyl transferase buffer (0.1 M Na-cacodylate, pH 6.8,
1.0mMCoCl, 0.1mMDTT) for 30minutes in a humid chamber.
Subsequently, the slides were washed 3  5 minutes with TB
buffer (300 mM NaCl, 30 mM tri-sodiumcitrate-dihydrate in
dH2O) and 3  5 minutes with dH2O. Thereafter, an epitope
retrieval step was performed with sodium citrate buffer pH 6VOL. 112 NO. 6 / DECEMBER 2019
Fertility and Sterility®(1 mM trisodium citrate [dihydrate]) þ 0.05% (v/v) Tween 20
(Sigma-Aldrich) in a microwave at maximum power (1 
10 minutes, 2 5 minutes, whereby after each microwave in-
cubation period, the initial volume was restored by adding
dH2O). The slides were cooled down to room temperature in
the sodium citrate buffer for 1 hour and washed with PBS (3
 5 minutes). Blocking was performed by incubating the sec-
tions in 10% normal goat serum and 5% bovine serum albu-
min (BSA) diluted in PBS, in a humid chamber for
30 minutes at room temperature. When we used dual ﬂuores-
cent staining, we performed sequential immunostaining
rounds for each primary antibody and its associated second-
ary,ﬂuorescent-tagged antibody, to reduce the risk of second-
ary antibody cross reaction. Thus, in the ﬁrst round, the ﬁrst
primary antibody (diluted in 5% BSA/PBS) was added to the
sections, and the slides were incubated in a humid chamber
at 4oC overnight. The second day, the slides were kept at
room temperature for 1 hour and then washed 3  5 minutes
with PBS. Subsequently, the appropriate secondary antibody
(diluted in PBS) was added and the slides were incubated for
1.5 hours in a humid chamber at room temperature. After
washing (3  5 minutes) in PBS, incubation with the second
primary antibody in 5% BSA/PBS followed overnight. On
the third day, we repeated the steps for addition of the appro-
priate secondary antibody for themost recently added primary
antibody to allow detection of the associated antigen. Finally,
slides were washed 3  5 minutes in PBS and mounted using
Prolong Gold Antifade reagent with DAPI.
Antibodies
Rabbit polyclonal anti-SYCP3 (noncommercial antibody
described in Lammers et al. [39]) at 1:10,000, mouse mono-
clonal anti-MLH1 (cat. 551091, BD Pharmingen) at 1:25,
mouse polyclonal anti-gH2AX at 1:10,000 (Millipore, 05-
636), rabbit polyclonal anti-H3Ser10ph at 1:1,000 (06-570,
Millipore), and mouse acrosome-speciﬁc antibody at 1:100
(noncommercial antibody described in Moore et al. [40])
were used. For secondary antibodies, we used goat anti-
rabbit alexa 488 IgG and goat anti-mouse alexa 546 IgG
(A-11008 and A-11003, respectively; Invitrogen), both at
1:500 dilution.Analyses of Fluorescent Immunostainings of
Human Testis Biopsy Sections
Quantitative analyses of meiotic entry, XY body formation,
and spermatid formation were performed at 200 or
1,000 magniﬁcation on an Axioplan 2 Carl Zeiss ﬂuores-
cence microscope, equipped with a digital camera (Cool-
snap-Pro; Photometrics). Only round tubules were scored
(deﬁned as tubules whereby the longest and shortest diameter
differed by less than two-fold). A minimum of 50 random
round tubules was evaluated per patient. On samples stained
with anti-gH2AX and anti-H3ser10ph the number of tubules
that contained at least one early cell was counted to determine
the percentage of early cell positive tubules (1,000magniﬁ-
cation, ECþT). The same analysis was performed for the XY
body, to determine the percentage of XY body positive tubules
(200 magniﬁcation, XYþT). In addition, the number of XYVOL. 112 NO. 6 / DECEMBER 2019bodies per XY body–positive tubule was assessed at 1,000
magniﬁcation. The percentage of tubules that contain sper-
matids and the most advanced spermatid stage reached
were determined on slides immunostained with the
acrosome-speciﬁc antibody (1,000 magniﬁcation, SPTþT).
Quantitative analyses of (apoptotic) metaphases were per-
formed using a 63 oil immersion Plan-Apochromat objec-
tive, Zeiss LSM700 confocal microscope equipped with a
digital camera (Axiocam MRm Rev.3 1388X1040). To obtain
the percentage of apoptotic metaphases, all metaphases in a
section were scored on samples stained with anti-gH2AX
and anti-H3ser10ph and classiﬁed as apoptotic if they were
also clearly positive for gH2AX immune signal (bright green
signal; care was taken to ensure separation of the red ﬂuores-
cent signal (H3S10ph, alexa 546) from the green ﬂuorescent
signal (gH2AX, alexa 488). The total number of metaphases
was normalized to the area analyzed (metaphases/mm2), and
the percentage of apoptotic metaphases was also calculated.
For counting MLH1 foci, Z-stacks from at least ﬁve
different spermatocytes were made per patient (63 objective
and 5 digital zoom). These Z-stacks were merged into two-
dimensional images (maximum projection). The number of
MLH1 foci was counted using the ‘‘Find Maxima’’ function
of the Image J software (41). The noise tolerance was set
manually. For each patient the average number of MLH1
foci per spermatocyte was then calculated.
Threshold Calculations
To establish baseline frequencies of tubule cross sections con-
taining cells at a speciﬁc spermatogenic stage, we determined
the normal range in our control samples for the following var-
iables: percentage early cell positive tubules (%ECþT), per-
centage XY body positive tubules (%XYþT), the number of
XY bodies per XY body positive tubule (XY/XYþT), the num-
ber of metaphases/mm2, the percentage of metaphases that
show apoptosis, and the number of MLH1 foci per nucleus.
The values observed for each variable in control patients
were averaged, and the SDs were calculated. The normal
range was determined using the mean  2 SD (95% conﬁ-
dence interval), which then served as threshold values. For
%ECþT and %XYþT, the lowest control value was not inside
the 95% conﬁdence interval, and in these cases, this lowest
control value was used as the threshold, since a Grubb's test
did not classify these as outliers. Finally, an additional
threshold for the number of metaphases/mm2 was established
by calculating the mean and SD values from the patients for
whom no XY bodies were observed (groups I and II); then
we set the minimal threshold value for reachingmeiotic meta-
phases at this mean þ2 SD. Table 1 shows an overview of
mean values and normal ranges. In all cases, absence of
more advanced stages indicated cell arrest at or around the
most advanced spermatogenic stage that still could be
observed.RESULTS
Patients
From 307 patients included in this study (see Materials and
Methods for criteria), 74 (24%) were assigned a JS below 3,1061
TABLE 1
Mean values and normal range of meiotic parameters.
Quantitative parameter Mean ± SD value in controls Normal range/thresholds
% of tubules containing cells in early meiotic prophase 88.2  18.6 100–43.9a
% of tubules containing XY body–positive nuclei 96.5  4.5 100–82.6a
No. of XY body–positive nuclei/XY body–positive tubule 20.2  6.2 32.6–7.74
No. of metaphases/mm2 7.54  2.5 12.54–2.53
Minimal metaphases/mm2 for meiotic metaphases >1.83b
% of apoptotic metaphases 4.6  3.4 0–11.5
No. of MLH1 foci 40.8  5.8 52.4–29.3
Note: SD = standard deviation.
a Threshold corresponds to the lowest value in controls (no outlier).
b Value based on mean þ 2 SD metaphases/mm2 in group I and group II patients.
Enguita-Marruedo. Meiotic metaphase arrest in men. Fertil Steril 2019.
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displayed variability of >2 in JS between left and right testis
biopsy, and 83 (27%) had JS 9–10. The 48 patients with JS 3–6
(including four patients for whom no JS was available but
maturation arrest was indicated by the pathologist) were
selected (see Supplemental Table 1 for available information).
In addition, 15 patients with JS 10 were randomly chosen and
used as controls. In total, 35 of the selected patients and
controls (JS 3–6 and JS 10, respectively) had also been
analyzed for AZF deletions and/or common CFTR mutations
and/or karyotype. Aberrations were found in ﬁve JS 3–6 pa-
tients: a pericentric inversion in chromosome 1 (P13;
46,XY,inv(1)(p21q32.1)), a balanced translocation between
the long arm of the Y-chromosome and the long arm of chro-
mosome 19 (P35; 46,X,t(Y;19)(q12;q13.3)), two AZFc (DAZ)
deletions (P10 and P17), and a heterozygote carrier of a
CFTR mutation (P41 (R117H/7T)). From the group of the JS
10 controls, one had been analyzed for genetic aberrations,
and this patient (C13) carried two CFTR mutations: 1717-
1G>A and Q1476X, most likely explaining the obstructive
azoospermia in this patient.Validation of Protein Markers and Classiﬁcation of
Meiotic Arrest Patients
We optimized an immunoﬂuorescent staining protocol (see
Materials and Methods for details) to assess meiotic progres-
sion in archived parafﬁn-embedded and formaldehyde-ﬁxed
biopsy material. We used a double immunostaining of anti-
phosphorylated H2AX (gH2AX) and anti-phosphorylated
H3 (H3Ser10ph) to assess whether checkpoint activation
and associated arrest occurred in the JS 3–6 patients:
gH2AX, marking meiotic DSBs and the XY body, was used
to verify entry into meiosis, progression of DSB repair, and
XY body formation (as a proxy for completion of synapsis
and repair). These are important parameters to assess activa-
tion of the two pachytene checkpoints. Figure 1A shows
low-magniﬁcation overviews of part of a tubule section con-
taining early spermatocytes (leptotene and zygotene, marked
by the presence of multiple gH2AX patches) and a section
containing pachytene nuclei with a clear XY body. In addi-
tion, H3Ser10ph immunostaining was used to identify
M-phase cells, and metaphases were identiﬁed by the combi-1062nation of this signal with a metaphase plate appearance of the
DNA (visualized by DAPI staining; Fig. 1B). Occasionally,
metaphases also displayed intense gH2AX signal along the
condensed chromosomes. Since this type of panchromosomal
gH2AX staining has been described as a hallmark of cells
entering apoptosis (42), we classiﬁed these aberrant meta-
phases as apoptotic (Fig. 1B, apoptotic metaphase). This
proved to be a very useful parameter to identify patients
with a meiotic metaphase arrest (see below).
Round, elongating, and condensing spermatids could be
reliably observed at low magniﬁcation using an antibody
that labels the acrosome, in combination with the DAPI signal
(Fig. 1C), and ﬁve subtypes were identiﬁed using higher
magniﬁcation (Supplemental Fig. 1A). Similarly, substages
of meiotic prophase could also be more clearly distinguished
at higher magniﬁcation, based on the pattern of gH2AX
staining (Supplemental Fig. 1B).
We quantiﬁed meiotic entry, XY body formation, and
(apoptotic) metaphases for the patients and controls. In addi-
tion, the presence and most advanced type of spermatids were
scored. We set thresholds for each parameter (Fig. 1D–1G,
Table 1) as described in Materials and Methods and inter-
preted the results by developing a decision tree (Fig. 1H). First,
we veriﬁed whether spermatogenesis progressed up to forma-
tion of meiotic DSBs (presence of early spermatocytes,
Fig. 1A, 1D). If this was not the case, arrest is likely to be pre-
meiotic, or very early meiotic, with a failure to induce meiotic
DSBs (group I). The next step was to determine whether
pachytene was reached as evidenced by XY body formation,
the hallmark of completion of both synapsis and DSB repair
(Fig. 1A, 1E). If XY bodies were not detected, this would indi-
cate activation of one of the two pachytene checkpoints, and
these patients were classiﬁed as group II. After assessing the
metaphase density in the whole patient group, we observed
a clear positive correlation between the number of meta-
phases/mm2 and the number of XY bodies per XYþT (R2 ¼
0.35; P< .0001; Fig. 1F), conﬁrming that formation of an
XY body is a prerequisite for metaphase entry. For group I
and II patients, all observed metaphases are expected to be
of mitotic origin. Thus, the values obtained for these two
groups of patients (group I: failure to enter meiosis; and group
II: failure to form the XY body) were used to deﬁne a threshold
of 1.83 metaphases/mm2, above which we consider additionalVOL. 112 NO. 6 / DECEMBER 2019
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Table 1). We identiﬁed eight patients that displayed a meta-
phase density below this threshold. These patients also dis-
played a reduced capacity to reach pachytene (Fig. 1F,
brown dots). For one of these patients, P46 (Fig. 1F, green
dot), we detected occasional spermatids in 38% of the tubules;
Supplemental Table 1), indicating that some cells were still
able to proceed through metaphase I and complete meiosis.
This patient was therefore classiﬁed as showing no arrest
(group VII). No spermatids were detected in the other seven
patients, and these were therefore classiﬁed as having a pre-
metaphase arrest (group III).
Next we assessed for the rest of the patients whether the
percentage of apoptotic meiotic metaphase cells was
increased compared with the normal range we established
in the control group (Table 1, Fig. 1G), and used this as mea-
sure of meiotic metaphase arrest. We then used the absence or
presence of spermatids in the tubules to classify these patients
as having a complete metaphase arrest (group IV) or an
incomplete metaphase arrest (group V). We also observed
that some patients did not show any sign of known check-
point activation, but where spermatids were completely lack-
ing, we classiﬁed these as postmetaphase arrest (group VI). In
the remaining patients we observed spermatids and no indica-
tions of checkpoint activation and classiﬁed these as no arrest
(group VII).
The frequencies of patients classiﬁed in each group is
shown in Figure 1I, and typical examples of immunostaining
patterns for each class are shown in Supplemental Figure 2.
Only four cases (8%) displayed complete activation of the
pachytene checkpoints (failure to form the XY body, group
II), while 44% displayed complete (27%, group IV) or partial
metaphase arrest (17%, group V), likely due to activation of
the SAC. In addition to the previously described pachytene
and metaphase arrests, we were able to deﬁne two additional
types of arrest: premetaphase and postmetaphase arrest (15%
[group III] and 13% [group VI], respectively). More detailed
descriptions of the criteria and speciﬁc aspects of the pheno-
types are outlined below for each group.
Meiotic Entry
The vast majority of patients displayed normal percentages of
tubules with early spermatocytes (%ESþT; Fig. 1D,
Supplemental Table 1). The single group I patient (P10, dark
blue dot in Fig. 1D) was one of the two patients that carried
an AZFc deletion. Two patients (P4 and P18) showed a reduc-
tion in %ESþT, based on the set normal range (Fig. 1D, lightQuantitative assessment of progression of meiosis in parafﬁn-embedded
pachytene spermatocytes (control sample). (B) Normal (control patient) an
(C) Spermatids (control sample). Magniﬁcations of the indicated late zyg
Figure 1B. Scale bar, 10 mm. (D) Percentage of tubules that contain early
in controls and JS 3–6 patients. The dark blue dot in panel D indicates t
below the threshold. Red dots in panel E indicate group II patients, and p
Correlation between the number of XY bodies per XYþT and the numbe
patients, and the green dot indicates one group VII patient with a valu
classiﬁcation of patients depending on the percentage of apoptotic me
indicated. (H) Decision tree for the classiﬁcation of patients; percentages a
Enguita-Marruedo. Meiotic metaphase arrest in men. Fertil Steril 2019.
=
1064blue dots). Based on the other assessed parameters, and
following the decision tree, these were subsequently classiﬁed
into group IV and V, respectively (Supplemental Table 1).XY Body Formation and Activation of Pachytene
Checkpoint
In line with a failure to enter meiosis, no tubules containing
XY bodies were found in the group I patient with no meiotic
entry (P10). Four additional patients displayed a complete
lack of XY bodies (Fig. 1E, red dots), and thus their spermato-
cytes were unable to reach the pachytene stage normally. This
indicates activation of either the synapsis-dependent or DSB
repair–dependent pachytene checkpoint (group II). Further
analysis of meiotic prophase in the four patients with pachy-
tene arrest revealed that the spermatocytes of P3 and P33
entered meiotic prophase normally, but groups of cells ar-
rested at leptotene or early zygotene. In contrast, only isolated
early spermatocytes where detected in P7 and P25, but these
appeared to have progressed further into zygotene, based on
the pattern of gH2AX (Fig. 2A, 2B).
Twenty-nine patients scored below the normal range of
percentage of XY body-positive tubules (XYþT; Fig. 1E,
pink dots, and Supplemental Table 1). To obtain a more sen-
sitive assessment of the efﬁciency of progression to pachy-
tene, independent of meiotic entry, we also assessed the
number of XY bodies per XYþT. This parameter showed a
strong positive correlation to the percentage of XYþT as ex-
pected (R2 ¼ 0.53; P< .0001; Fig. 2C). In patients with a
reduced number (<7.7) of XY bodies per XYþT, spermato-
cytes reach pachytene with reduced efﬁciency. This points
to cell loss at some point between meiotic entry and
pachytene.Meiotic Metaphase and Activation of the SAC
Other than a reduced capacity to reach pachytene (Fig. 1F and
Fig. 2C), we observed no speciﬁc aberrant feature that could
explain the failure to reach meiotic metaphase for group III
patients, except for spermatocytes of P44, which often dis-
played panchromosomal gH2AX staining (Fig. 2D). As
described above for the apoptotic metaphases, this is a hall-
mark of apoptosis and provides an explanation for the loss
of spermatocytes in this patient.
Twenty-one patients displayed an increased percentage
of apoptotic metaphases compared with controls (Fig. 1G),
indicating frequent activation of the SAC, leading to
apoptosis. Most of these patients also displayed a reducedtestis sections. (A) Immunostaining of early meiotic prophase and
d apoptotic (patient displaying metaphase arrest) metaphase nuclei.
otene (LZ) and pachytene (XY) nucleus are shown in Supplemental
spermatocytes and (E) percentage of tubules that contain XY bodies
he group I patient, and light blue dots indicate patients with values
ink dots indicate JS 3–6 patients with values below the threshold. (F)
r of metaphases/mm2 (P<.0001). Dark brown dots indicate group III
e below the threshold for reaching meiotic metaphase. (G) Further
taphases and the presence/absence of spermatids. Color codes as
nd colors correspond to the pie diagram shown in panel I.
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FIGURE 2
Efﬁciency of XY body formation and aberrations in gH2AX pattern in spermatocytes of group II, III, IV, and VI patients. (A and B) Aberrations in the
gH2AX pattern (green staining) in samples of patients displaying failure to form the XY body (pachytene arrest, group II). Intriguingly, the
spermatocyte nuclei of P25 were half the size of the nuclei observed in the other three patient biopsies in this group. This could indicate a gross
alteration in nuclear/chromatin structure in the spermatocytes of this patient, but ﬁxation artefacts cannot be excluded. (C) Positive correlation
between the percentage of tubules with XY bodies and the number of XY bodies per XYþT. Red dots (four on top of each other) indicate
group II patients; pink dots and brown dots (all group III patients) are patients for whom both parameter values were below the threshold; pink
dots with dark gray outlines represent values whereby only the number of XY bodies per XYþT was reduced; and dark gray dots with pink
outlines only display a reduced percentage of tubules with XY bodies. Dark gray dots represent all JS 3–6 patients who displayed values within
the normal range for both parameters, and light gray dots represent the controls. (D) Representative images of aberrant gH2AX staining in
samples of P44 (group III, premetaphase arrest), P9 (group IV, complete metaphase arrest), P40 (group IV), P13 (group IV), and P42 (group VI,
postmetaphase arrest). Pannuclear staining is observed for P44, P9, and P42. Spermatocytes of P40 display many persistent small patches of
gH2AX staining. For three other group IV patients (P13, P14, and P24) we often observed abnormal XY bodies or two (or more) gH2AX-positive
XY body–like structures (see also Supplemental Fig. 3). For P13 (46,XY,inv(1)(p21q32.1)) shown here, the presence of an extra XY body–like
gH2AX domain most likely represents an incompletely synapsed bivalent of chromosome 1 (due to the inversion), in addition to a normal XY
body. Scale bars, 10 mm.
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ORIGINAL ARTICLE: ANDROLOGYpercentage of tubules with XY bodies and/or a reduced num-
ber of XY bodies per XYþT, but no signiﬁcant correlation be-
tween either of these two parameters and the percentage of
apoptotic metaphases was observed (%XYþT, R2 ¼
0.00647, P¼ .6411; XY bodies/XYþT, R2 ¼ 0.00729,
P¼ .6205). The most advanced spermatid types present in bi-
opsies of patients with partial metaphase arrest (group V) were
mostly early spermatids (type 2 or 3). Thus, when the SAC is
frequently activated, the few cells that are able to proceed
through metaphase are likely to fail in completing spermato-
genesis normally.
Similar to P44 of group III (failure to reachmetaphase), P9
of group IV (complete metaphase arrest) also displayed pan-
chromosomal gH2AX staining indicating apoptosis in sper-
matocyte cells that were pre-M phase (Fig. 2D). For P40,
also of group IV, frequent occurrence of multiple small
patches of gH2AX in spermatocytes indicated problems in
completing meiotic DNA DSB repair in (Fig. 2D). In addition,
for group IV patients P13, P14, and P24 we often observed an
extra XY body–like gH2AX signal in pachytene spermato-
cytes, which would indicate more localized chromosome
pairing problems (Fig. 2D, and Supplemental Fig. 3). P13
indeed carried a large inversion in chromosome 1
(46,XY,inv(1)(p21q32.1)), but for the others karyotyping did
not reveal chromosome aberrations. No such atypical
gH2AX signals were detected in group V patients. From the
six patients in group VI (postmetaphase arrest) we observed
apoptotic nuclei in only one (P42; Fig. 2D), and no other aber-
rant features explaining the lack of spermatids could be
observed in the other patients in this group.Complete Metaphase Arrest and Crossover
Frequency
Lack of crossover formation is a well-known trigger for SAC
activation in mouse spermatocytes (43). To assess crossover
frequency in group IV (complete metaphase arrest) patients,
we used antibodies against MLH1 (marker of crossover sites
at pachytene) (36) and SYCP3 (marker of the chromosomal
axes; Fig. 3A, 3B). Two patients were excluded from the anal-
ysis, since staining for MLH1 and SYCP3 was unsuccessful.
Four patients, including the three patients for whom we
observed multiple XY body–like structures (P13, P14, and
P24, Supplemental Fig. 3), displayed a reduced mean number
of MLH1 foci (mean value range, 10–27) compared with con-
trols (40.8 5.8; Fig. 3B). We observed a negative correlation
between the percentage of apoptotic metaphases and the
mean number of MLH1 foci (R2 ¼ 0.32; P¼ .014; Fig. 3C).DISCUSSION
Metaphase Arrest Is the Most Frequent Type of
Male Meiotic Arrest
Herein we have shown that the metaphase checkpoint is more
frequently uniformly activated than the pachytene check-
point. This is in contrast to observations in the mouse, where
knockout of genes expected to exert meiotic prophase-
speciﬁc functions most frequently results in activation of
one or both of the two pachytene checkpoints (9, 44).1066Examples are genes required for DSB formation (Spo11,
Mei4) (45–47), for meiotic DSB repair (Dmc1, Msh4, Msh5,
Meiob) (48–51), and/or for chromosome pairing
(synaptonemal complex or cohesin components: Sycp1,
Sycp2, Sycp3, Smc1b, and more) (52–54). Therefore, such
genes might be mutated in patients displaying failure to
form XY bodies. In a recent detailed study of 10
azoospermic men (32), two types of male meiotic prophase
arrest were proposed, based on the absence (type I) or
presence (type II) of the XY body. However, meiotic
metaphase was not analyzed in this study. Since the type II
patients were described to display aberrations in the
expression of cell cycle genes (32), it could be worthwhile to
assess whether spermatocytes in these patients might also
arrest at metaphase instead of at prophase.
Metaphase arrest in mice has been observed mainly when
crossover formation was affected. Mutation of genes such as
Mlh1 (6, 55) and Rnf212 (56) almost completely abolish
crossover formation. Mutation of Shoc1 (57) or of the
X-linked Tex11 gene (58) leads to a somewhat more subtle
and variable reduction in the number of crossovers (19%
for Shoc1 and 30% for Tex11), but still in combination
with complete metaphase arrest. Mutations in TEX11 have
also been reported in a small percentage of men diagnosed
with a meiotic arrest phenotype (59, 60). These four genes
would be interesting candidates to screen for mutations in
patients displaying metaphase arrest in combination with a
reduction in MLH1 foci.
Still, crossover frequency was normal in most patients
displaying complete metaphase arrest in this study. In these
cases, alterations in other proteins involved in the
metaphase-anaphase transition or functioning in cell cycle
regulation may cause the observed arrest. In addition, a
mild reduction in the number of crossovers (e.g., lack of the
obligate crossover in the pseudoautosomal region of the XY
pair), which would not result in a signiﬁcant decrease in
crossover frequency, could still trigger metaphase arrest in
some of the patients.
Two of the patients whomwe analyzed were carriers of an
AZFc deletion. These patients are known to present variable
phenotypes (ranging from Sertoli cell only to oligozoosper-
mia) (61). In our analyses, one patient (P10) displayed failure
of meiotic entry, and the other (P17) a complete metaphase ar-
rest, conﬁrming this variability.Premetaphase and Postmetaphase Arrest: Novel
Checkpoints or Necrosis?
In 15% of the testis biopsies we observed an arrest before
meiotic metaphase (group III). Similar defects are observed in
mice lacking Hspa2-/- (62), Repro8-/- (63), Cyclin A1 (64), or
Rpl10l, a testis-speciﬁc retrogene present in all eutherians
(65). It is not known whether this lack of cells at meiotic meta-
phase I involves activation of a speciﬁc checkpoint or a
collapse of the developmental potential of the cells after entry
into meiotic prophase. Our patients in group III also displayed
reduced XY body formation, indicating clear problems in
reaching pachytene in addition to a failure to reach metaphase.VOL. 112 NO. 6 / DECEMBER 2019
FIGURE 3
Analyses of crossover frequency. (A)MLH1 (green) andSYCP3 (red) in a control andpatient (P13, group IV) pachytenenucleus. Scale bars, 10mm. (B) Number of
MLH1 foci per nucleus (dots) and mean values (horizontal bars) for each analyzed patient. (C) Negative correlation between the number of MLH1 foci and the
percentage of apoptoticmetaphases. Patient IDs forwhompachytene nuclei frequently displayedmore than oneXYbody–like structure (Fig. 2D, Supplemental
Fig. 3) are in italics; bold patient IDs indicate patients with known chromosomal aberration. The dashed line shows the threshold.
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ORIGINAL ARTICLE: ANDROLOGYPostmetaphase arrest (group VI) could involve some form
of cell death within a short period between the ﬁrst meiotic di-
vision and early spermatid stages. Early spermatid arrest oc-
curs in mice in which the expression of the transcription
factor CREMtau has been disrupted (66). Mutation of ZFY
could also be suspected as a cause of the failure to develop
further than themeiotic divisions. Inmice,Zfy1 andZfy2 pro-
mote completion of meiosis II (67). In men, there is a single
ZFY gene (68).
Since apoptotic nuclei were observed in the biopsies of
only few group III and group VI patients, activation of an
(apoptotic) pathway not involving pannuclear gH2AX forma-
tion (like necroptosis or necrosis) may explain the rapid loss of
cells in those patients. In addition, or alternatively, malfunc-
tioning cells may detach from the Sertoli cells, followed by
sloughing into the lumen, as was previously reported for
certain mouse models (69).
In conclusion, the double immunostaining with anti-
gH2AX and anti-H3S10ph in combination with the decision
tree we developed here is a highly feasible approach to diag-
nose meiotic arrest phenotypes in azoospermic men. Our
approach can distinguish between failure in chromosome
pairing/DSB repair and failure in the metaphase to anaphase
transition. Metaphase arrest was deﬁned as the most frequent
type of meiotic arrest. Uniform activation of meiotic check-
points suggests a genetic cause of spermatogenic arrest.
Thus, this technique can also be used as a tool to preselect pa-
tients for sequencing in the search for infertility genes.
For men with nonobstructive forms of severe oligozoo-
spermia and azoospermia, intracytoplasmic sperm injection
can be used for fertility treatment, if viable spermatozoa or
even spermatids can be retrieved after testicular sperm extrac-
tion (70, 71). If partial activation of meiotic checkpoints is
observed in such patients, further research is recommended
to determine whether the surviving gametes have increased
frequencies of (epi)genetic aberrations before using them for
infertility treatment.
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ORIGINAL ARTICLE: ANDROLOGYEl bloqueo meiotico sucede mas frecuentemente durante la metafase y a menudo es incompleta en hombres azoospermicos
Objetivo: Establecer que puntos de control meioticos son activados en varones con alteracion grave en la espermatogenesis para me-
jorar la caracterizacion fenotípica de anomalías meioticas.
Dise~no: Estudio retrospectivo observacional.
Lugar: Laboratorio de investigacion de centro medico universitario y clínica de andrología.
Pacientes: Cuarenta y ocho pacientes con alteraciones graves en la espermatogenesis conﬁrmadas (puntuacion Johnsen 3-6) y 15 con-
troles (puntuacion Jonhsen 10).
Intervenciones: Ninguna.
Resultados principales: Evaluacion cuantitativa del analisis de inmunoﬂuorescencia de marcadores especíﬁcos para determinar el in-
icio de la meiosis, el apareamiento de cromosomas, la progresion de la reparacion de la rotura de doble cadena del ADN, la formacion del
entrecruzamiento, la formacion de metafases meioticas, el bloqueo de la metafase y la formacion de espermatides, dando como resul-
tado una nueva clasiﬁcacion de tipos de bloqueos meioticos humanos.
Resultado(s): El bloqueo completo metafasico fue el fenomeno mas frecuente (27%), los pacientes con el porcentaje de metafases
apoptotico mas elevado tambien mostraron una reduccion en el numero de quiasmas. Se observo un bloqueo incompleto de la metafase
en un 17% de los pacientes. Solo cuatro pacientes (8%) fueron incapaces de ﬁnalizar el apareamiento meiotico de cromosomas provo-
cando un bloqueo en paquitene. Se deﬁnieron dos nuevos tipos de bloqueo meiotico: bloqueo en pre-metafase y post-metafase (15% y
13%, respectivamente).
Conclusion(es): El bloqueo meiotico en hombres sucede con mayor frecuencia durante la metafase meiotica. Este bloqueo puede ser
incompleto, dando como resultado un bajo numero de espermatides y a menudo ocurre asociado a una menor frecuencia de entrecru-
zamientos. El enfoque fenotípico aquí descrito proporciona una vision mecanicista para ayudar a identiﬁcar genes responsables de la
infertilidad y para evaluar las correlaciones genotipo – fenotipo en casos particulares.1070 VOL. 112 NO. 6 / DECEMBER 2019
SUPPLEMENTAL FIGURE 1
Identiﬁcation of spermatocyte and spermatid substages. (A) Types of spermatids identiﬁed in control sample. (B) Meiotic prophase stages present in
controls (late zygotene and late pachytene nuclei are magniﬁcations of the nuclei indicated in Fig. 1A). Immunostained antigens are as indicated on
the images. Scale bar, 10 mm.
Enguita-Marruedo. Meiotic metaphase arrest in men. Fertil Steril 2019.
VOL. 112 NO. 6 / DECEMBER 2019 1070.e1
Fertility and Sterility®
SUPPLEMENTAL FIGURE 2
Example overview images of representatives from each patient group. Representative wideﬁeld immunoﬂuorescent images of each patient grouped
as indicated. Patient numbers are shown. Blue (DAPI) green (gH2AX or acrosome as indicated) and red (H3S10p) immunoﬂuorescent signals are
shown separately. Examples of early spermatocytes (ES), pachytene spermatocytes (XY), mitotic (M*) and (apoptotic) meiotic metaphases ((A)
M), and spermatids (Spt) are indicated with arrows. Scale bar, 20 mm.
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SUPPLEMENTAL FIGURE 3
Aberrant XY body–like structures in some group IV patients. Pachytene nuclei from three patients with aberrant XY body–like structures; P14, P13
(46XY, inv(1)(p21q32.1)), and P24, all displaying varying frequencies of aberrant XY body–like structures, as indicated in Table 1 (lower right
corner). The variable ‘‘n’’ indicates the number of nuclei that were analyzed. All three patients also displayed a reduction in the average MLH1
foci number (Fig. 3). Scale bars, 10 mm.
Enguita-Marruedo. Meiotic metaphase arrest in men. Fertil Steril 2019.
VOL. 112 NO. 6 / DECEMBER 2019 1070.e3
Fertility and Sterility®
